Euroespes SA
MAD:EEP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Euroespes SA
MAD:EEP
|
ES |
|
O
|
OsstemImplant Co Ltd
KOSDAQ:048260
|
KR |
|
S
|
S&P Global Inc
XETRA:MHL
|
US |
|
S
|
Strategic Hospitality Extendable Freehold and Leasehold Real Estate Investment Trust
SET:SHREIT
|
TH |
|
L
|
Linedata Services SA
SWB:LN4
|
FR |
|
Guangdong Topstrong Living Innovation and Integration Co Ltd
SZSE:300749
|
CN |
|
Veris Residential Inc
NYSE:VRE
|
US |
|
Darkpulse Inc
OTC:DPLS
|
US |
|
G
|
Goviex Uranium Inc
SWB:7GU
|
CA |
|
Metropole Television SA
PAR:MMT
|
FR |
|
Naseej International Trading Co
SAU:1213
|
SA |
Balance Sheet
Balance Sheet Decomposition
Euroespes SA
Euroespes SA
Balance Sheet
Euroespes SA
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
3
|
2
|
2
|
2
|
1
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
3
|
2
|
2
|
2
|
1
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Accounts Receivables |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
1
|
1
|
1
|
4
|
3
|
3
|
3
|
2
|
1
|
|
| PP&E Net |
2
|
2
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
|
| Intangible Assets |
1
|
1
|
3
|
3
|
4
|
3
|
4
|
4
|
4
|
3
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
2
|
2
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
1
|
2
|
1
|
1
|
1
|
0
|
0
|
|
| Total Assets |
6
N/A
|
7
+6%
|
9
+32%
|
9
+5%
|
13
+37%
|
11
-11%
|
12
+3%
|
12
+5%
|
10
-16%
|
8
-23%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
4
|
|
| Other Current Liabilities |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Current Liabilities |
2
|
2
|
1
|
2
|
2
|
2
|
1
|
2
|
3
|
5
|
|
| Long-Term Debt |
1
|
1
|
3
|
2
|
2
|
2
|
3
|
3
|
3
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
4
N/A
|
4
+2%
|
5
+39%
|
5
+3%
|
4
-17%
|
4
-3%
|
4
+1%
|
5
+13%
|
5
+8%
|
5
-4%
|
|
| Equity | |||||||||||
| Common Stock |
3
|
3
|
3
|
3
|
6
|
6
|
7
|
7
|
7
|
7
|
|
| Retained Earnings |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
4
|
6
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
3
N/A
|
3
+12%
|
4
+24%
|
4
+8%
|
8
+105%
|
7
-15%
|
7
+4%
|
7
0%
|
5
-33%
|
3
-42%
|
|
| Total Liabilities & Equity |
6
N/A
|
7
+6%
|
9
+32%
|
9
+5%
|
13
+37%
|
11
-11%
|
12
+3%
|
12
+5%
|
10
-16%
|
8
-23%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
4
|
5
|
5
|
5
|
10
|
11
|
12
|
12
|
12
|
12
|
|